Australia markets closed

Merck & Co., Inc. (MRK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
127.28+0.40 (+0.32%)
As of 02:12PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close126.88
Open126.82
Bid127.10 x 900
Ask127.11 x 1000
Day's range125.35 - 127.36
52-week range99.14 - 133.10
Volume2,933,102
Avg. volume8,354,061
Market cap322.404B
Beta (5Y monthly)0.40
PE ratio (TTM)909.14
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield3.08 (2.43%)
Ex-dividend date14 Mar 2024
1y target estN/A
  • Zacks

    4 Large Drug Stocks to Hold on to Amid Industry Challenges

    Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.

  • Insider Monkey

    Here’s Why Merck & Co. (MRK) Outperformed in Q1

    Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]

  • Zacks

    How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?

    Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda, when the company reports first-quarter 2024 earnings.